COLORADO – July 2025 – Rocky Mountain Cancer Centers (RMCC) proudly announces that four of its esteemed physician oncologists in the Colorado Springs area have been recognized in Colorado Springs Magazine’s prestigious “Top Docs” list for 2025. This significant accolade is particularly noteworthy as these physicians are nominated and chosen by their fellow Colorado Springs-area doctors, signifying a profound level of trust and respect within the medical community. 

The entire RMCC team proudly congratulates our esteemed colleagues, Dr. Matthew Logsdon, Dr. Markus Maurice, Dr. Michael Monticelli, and Dr. Timothy Murphy, on their well-deserved "Top Docs" nominations. This recognition for their excellence in the Colorado Springs region is a source of immense pride for all of us. These nominations highlight the exceptional dedication and expertise of RMCC's physicians, who focus solely on cancer care, providing patients with unmatched experience and in-depth knowledge across a wide range of cancer types and treatments.

"We are incredibly proud to see our physicians recognized by their peers in the Colorado Springs medical community," said Manojkumar Bupathi, MD, MS, president and medical oncologist at RMCC. "This peer-to-peer recognition is the highest form of respect and speaks volumes about the dedication, skill, and compassionate care our oncologists provide every day. It's a testament to their unwavering commitment to advancing cancer treatment and ensuring the best possible outcomes for our patients."

RMCC is uniquely positioned with multiple locations across Colorado Springs and southern Colorado, bringing world-class cancer care, including advanced therapies and clinical trials, conveniently to patients within their communities for local accessibility. The physician oncologists at RMCC are dedicated to creating personalized treatment plans for each patient, utilizing the latest evidence-based practices and innovative research.

"For our patients, these 'Top Doc' nominations offer a vital reassurance that they are receiving care from some of the most respected and knowledgeable cancer specialists in the region," commented Alonso Pacheco, MD, medical director, medical oncologist, and hematologist at Rocky Mountain Cancer Centers. "Beyond medical treatment, our top doctors at RMCC are committed to offering comprehensive support services, ensuring that patients and their families receive compassionate care and guidance throughout their entire cancer journey. This holistic approach, combined with cutting-edge treatments and access to clinical trials, truly sets RMCC apart."

The recognition in Colorado Springs Magazine's "Top Docs" list underscores RMCC's commitment to excellence in oncology and its mission to deliver leading-edge cancer care close to home for patients throughout Colorado.

RMCC is part of The U.S. Oncology Network, a highly respected national organization collaborating to advance innovative care and deliver optimal outcomes. As Colorado’s leader in cancer treatment, we’ve been delivering world-class cancer care with compassion and expertise for more than 30 years, and we make our patients’ lives easier by offering coordinated care access in 19 locations throughout Colorado. So, if you find yourself facing new challenges in your health journey, we’ll be on your side, empowering Your Courage with Our Proven Experience.

# # #

Rocky Mountain Cancer Centers (RMCC) is an independent, physician-led practice that delivers leading-edge technology and treatment options and conducts innovative research. For more than 30 years, RMCC has pioneered community-based care to enable more cancer patients to receive high-quality treatment while staying close to the support of family and friends.

Rocky Mountain Cancer Centers treats more adult cancer than any other healthcare organization in Colorado, providing 19 locations and a network of 54 physicians specializing in cancer care throughout the state. RMCC is collectively focused on treating cancer and blood disorders with advanced technology and innovative research no matter where you live, while taking a community-based approach of integrated subspecialty oncology care. This enables patients to access leading-edge treatment while living at home and receiving the critical support of family and friends.

Patients who are treated at RMCC can participate in some of the most promising national clinical trials for a broad range of cancers. RMCC has played a role in the development of more than 100 FDA-approved cancer-fighting drugs – about one-third of cancer therapies approved by the FDA to date. At any given time, more than 150 national clinical trials are open throughout The Network.

Media Contacts
RMCC Media
RMCCmedia@usoncology.com